L. E. B. Johansson

7.0k citations

170 papers · 4.2k · 2 hit papers · h-index 34

Impact in

Endocrinology, Diabetes and Metabolism top 1%
- Diabetes Treatment and Management
- Diet, Metabolism, and Disease
Astronomy and Astrophysics top 2%
- Astrophysics and Star Formation Studies
- Stellar, planetary, and galactic studies

Papers in

Astronomy and Astrophysics 72
- Astrophysics and Star Formation Studies 62
- Stellar, planetary, and galactic studies 29
Spectroscopy 40
- Molecular Spectroscopy and Structure 21
- Spectroscopy and Laser Applications 18

Co-authors: Håkan Åhlström (26 shared papers)Joel Kullberg (15 shared papers)Jan Oscarsson (6 shared papers)Jan W. Eriksson (8 shared papers)Lars Lind (7 shared papers)Olle Korsgren (14 shared papers)Olof Eriksson (19 shared papers)Per‐Anders Jansson (3 shared papers)
Journals: Astronomy and Astrophysics (13 papers)Diabetes (6 papers)The Astrophysical Journal (6 papers)Scientific Reports (4 papers)Journal of Nuclear Medicine (4 papers)
Partner nations: Sweden United States Germany

In The Last Decade

L. E. B. Johansson

159 papers receiving 4.1k citations

L. E. B. Johansson's Hit Papers

align trajectories log scale

Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging 2021 · 163 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Alimentary Pharmacology & Therapeutics
2018 Diabetologia

Peers

Countries citing papers authored by L. E. B. Johansson

Since Specialization

Citations

This map shows the geographic impact of L. E. B. Johansson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. E. B. Johansson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. E. B. Johansson more than expected).

Fields of papers citing papers by L. E. B. Johansson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. E. B. Johansson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. E. B. Johansson. The network helps show where L. E. B. Johansson may publish in the future.

Co-authors

The 25 scholars most cited alongside L. E. B. Johansson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L. E. B. Johansson Line = papers co-authored together L. E. B. Johansson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 170 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study Diabetologia ·Jan W. Eriksson, Per Lundkvist, Per‐Anders Jansson, L. E. B. Johansson, Mats Kvarnström, Linda Moris, Tasso Miliotis, Gun‐Britt Forsberg, Ulf Risérus, Lars Lind, Jan Oscarsson Hit paper breakdown →	2018	295
2	The SGLT2 Inhibitor Dapagliflozin Reduces Liver Fat but Does Not Affect Tissue Insulin Sensitivity: A Randomized, Double-Blind, Placebo-Controlled Study With 8-Week Treatment in Type 2 Diabetes Patients Diabetes Care ·Aino Latva‐Rasku, Miikka‐Juhani Honka, Joel Kullberg, Nina Mononen, Terho Lehtimäki, Juha Saltevo, Anna K. Kirjavainen, Virva Saunavaara, Patricia Iozzo, L. E. B. Johansson, Jan Oscarsson, Jarna C. Hannukainen, Pirjo Nuutila	2019	192
3	Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging Alimentary Pharmacology & Therapeutics ·Anne Flint, Grit Andersen, Paul Hockings, L. E. B. Johansson, Anni Morsing, Mads Sundby Palle, Thomas J. Vogl, Rohit Loomba, Leona Plum‐Mörschel Hit paper breakdown →	2021	163
4	Clinical and Experimental Pancreatic Islet Transplantation to Striated Muscle Diabetes ·Gustaf Christoffersson, Johanna Henriksnäs, L. E. B. Johansson, Charlotte Rolny, Håkan Åhlström, José Caballero-Corbalán, Ralf Segersvärd, Johan Permert, Olle Korsgren, Per‐Ola Carlsson, Mia Phillipson	2010	134
5	Whole-body adipose tissue analysis: comparison of MRI, CT and dual energy X-ray absorptiometry British Journal of Radiology ·Joel Kullberg, John Brandberg, J.‐E. Angelhed, Hans Frimmel, E BERGELIN, Lars Strid, Håkan Åhlström, L. E. B. Johansson, Lars Lönn	2009	125
6	The Pharmacological Characterization of a Novel Selective 5-Hydroxytryptamine1A Receptor Antagonist, NAD-299 Journal of Pharmacology and Experimental Therapeutics ·L. E. B. Johansson, Daniel Sohn, Seth-Olof Thorberg, D M Jackson, Diana Kelder, Lars‐Gunnar Larsson, Lucy Rényi, Svante B. Ross, Carin Wallsten, (unknown), Ping Hu, Eva Jerning, Nina Mohell, Anita Westlind‐Danielsson	1997	111
7	Late-life obesity is associated with smaller global and regional gray matter volumes: a voxel-based morphometric study International Journal of Obesity ·Samantha J. Brooks, Christian Benedict, Jonathan Burgos, Matthew J. Kempton, Joel Kullberg, Richard Nordenskjöld, Lena Kilander, Rūta Nylander, (unknown), L. E. B. Johansson, Håkan Åhlström, Lars Lind, Helgi B. Schiöth	2012	109
8	Felodipine kinetics in healthy men Clinical Pharmacology & Therapeutics ·Boo Edgar, C G Regårdh, G. Johnsson, L. E. B. Johansson, Per Lundborg, Ida E. Löfberg, Ola Rönn	1985	101
9	Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation Hypertension ·Jan W. Eriksson, Per‐Anders Jansson, Bo Carlberg, Anders Hägg, Lisa Kurland, Maria Svensson, Håkan Åhlström, Conny Ström, Lars Lönn, Kristina Öjbrandt, L. E. B. Johansson, Lars Lind	2008	96
10	Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study Journal of clinical lipidology ·Jan Oscarsson, Kristina Önnerhag, Ulf Risérus, Mattias Sundén, L. E. B. Johansson, Per‐Anders Jansson, Linda Moris, Peter M. Nilsson, Jan W. Eriksson, Lars Lind	2018	90
11	Two‐point dixon method with flexible echo times Magnetic Resonance in Medicine ·Johan Berglund, Håkan Åhlström, L. E. B. Johansson, Joel Kullberg	2010	89
12	Plasminogen Activator Inhibitor-1 4G/5G Polymorphism and Risk of Stroke Stroke ·Per-Gunnar Wiklund, Lennart Nilsson, Sofie Nilsson Ardnor, Per Eriksson, L. E. B. Johansson, Birgitta Stegmayr, Anders Hamsten, Dan Holmberg, Kjell Asplund	2005	84
13	In Vivo Imaging of the Glucagonlike Peptide 1 Receptor in the Pancreas with ⁶⁸Ga-Labeled DO3A-Exendin-4 Journal of Nuclear Medicine ·Ram Kumar Selvaraju, Irina Velikyan, L. E. B. Johansson, Zhanhong Wu, Иван Тодоров, J E Shively, Fouad Kandeel, Olle Korsgren, Olof Eriksson	2013	81
14	Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients Acta Radiologica ·Goran Abdulqadhr, Daniel Molin, Gunnar Åström, Madis Suurküla, L. E. B. Johansson, Hans Hagberg, Håkan Åhlström	2011	80
15	Detection of Metastatic Insulinoma by Positron Emission Tomography With [68Ga]Exendin-4—A Case Report The Journal of Clinical Endocrinology & Metabolism ·Olof Eriksson, Irina Velikyan, Ram Kumar Selvaraju, Fouad Kandeel, L. E. B. Johansson, Gunnar Antoni, Barbro Eriksson, Jens Christian Hedemann Sørensen, Olle Korsgren	2014	79
16	Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study The Lancet. Gastroenterology & hepatology ·Rohit Loomba, Eric Lawitz, Juan P. Frías, Grisell Ortiz‐Lasanta, L. E. B. Johansson, Bridgette Boggess Franey, Linda Morrow, Moti Rosenstock, Cynthia L. Hartsfield, Chaoyin Chen, Leo Tseng, R. Will Charlton, Hank Mansbach, Maya Margalit	2022	73
17	Molecular Cloud Structure in the Magellanic Clouds: Effect of Metallicity The Astrophysical Journal ·Soojong Pak, D. T. Jaffe, E. F. van Dishoeck, L. E. B. Johansson, R. S. Booth	1998	71
18	N₂H⁺(1–0) survey of massive molecular cloud cores Astronomy and Astrophysics ·L. E. Pirogov, И. И. Зинченко, P. Caselli, L. E. B. Johansson, Philip C. Myers	2003	70
19	Automated analysis of liver fat, muscle and adipose tissue distribution from CT suitable for large-scale studies Scientific Reports ·Joel Kullberg, Anders Hedström, John Brandberg, Robin Strand, L. E. B. Johansson, Göran Bergström, Håkan Åhlström	2017	66
20	Promotive effect by prostasomes on normal human spermatozoa exhibiting no forward motility due to buffer washings European Journal of Obstetrics & Gynecology and Reproductive Biology ·Roberto Fabiani, L. E. B. Johansson, Örjan Lundkvist, U. Ulmsten, Gunnar Ronquist	1994	53

About L. E. B. Johansson

L. E. B. Johansson is a scholar working on Astronomy and Astrophysics, Spectroscopy, Epidemiology, Endocrinology, Diabetes and Metabolism and Atmospheric Science, having authored 170 papers that have together received 4.2k indexed citations. Recurring topics across this work include Astrophysics and Star Formation Studies (62 papers), Stellar, planetary, and galactic studies (29 papers), Molecular Spectroscopy and Structure (21 papers), Spectroscopy and Laser Applications (18 papers), Atmospheric Ozone and Climate (17 papers), Diabetes Treatment and Management (17 papers), Liver Disease Diagnosis and Treatment (15 papers) and Pancreatic function and diabetes (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (905 citations), Astronomy and Astrophysics (813 citations), Epidemiology (983 citations), Spectroscopy (399 citations) and Hepatology (125 citations). L. E. B. Johansson has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Håkan Åhlström, Joel Kullberg, Jan Oscarsson, Jan W. Eriksson, Lars Lind, Olle Korsgren, Olof Eriksson, Per‐Anders Jansson, Ulf Risérus and R. S. Booth. Their work appears in journals such as Astronomy and Astrophysics, Diabetes, The Astrophysical Journal, Scientific Reports and Journal of Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

L. E. B. Johansson

Impact in

Papers in i

In The Last Decade

L. E. B. Johansson

L. E. B. Johansson's Hit Papers

Peers

Countries citing papers authored by L. E. B. Johansson

Fields of papers citing papers by L. E. B. Johansson

All Works

About L. E. B. Johansson

Explore authors with similar magnitude of impact

Papers in